Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Inst Pasteur Tunis ; 85(1-4): 69-80, 2008.
Artigo em Francês | MEDLINE | ID: mdl-19469418

RESUMO

Snake venoms are a rich natural source of bioactive molecules, such as peptides, proteins and enzymes, more and more used in biomedical research in diagnostic or therapeutic purposes. The protein components of snake venoms belong to diverse families such as serine proteases, phospholipases, disintegrins, metalloproteinases and C-type lectins. Due to their effects on various receptors such as GPIb, GPVI, alpha2beta1..., the C-type lectins were considered, in first time, as modulators of the platelet aggregation. Recently, some of them have been described for their anti-tumoral potential effect due to their capacity to inhibit adhesion, migration, proliferation and invasion of different cancer cell lines. Also, the C-type lectins have a powerful antiangiogenic effect in vivo and in vitro by interacting with integrins of endothelial cells.


Assuntos
Transformação Celular Neoplásica/efeitos dos fármacos , Lectinas Tipo C/uso terapêutico , Neovascularização Patológica/prevenção & controle , Agregação Plaquetária/efeitos dos fármacos , Venenos de Serpentes/química , Animais , Linhagem Celular Tumoral/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Integrina alfa2beta1/efeitos dos fármacos , Integrina alfa5beta1/efeitos dos fármacos , Lectinas Tipo C/química , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/efeitos dos fármacos , Complexo Glicoproteico GPIb-IX de Plaquetas/efeitos dos fármacos
2.
Arch Inst Pasteur Tunis ; 84(1-4): 49-55, 2007.
Artigo em Francês | MEDLINE | ID: mdl-19388583

RESUMO

The scorpionic and ophidian envenomations are a serious public health problem in Tunisia especially in Southeastern regions. In these regions Artemisia campestris L is a plant well known which has a very important place in traditional medicine for its effectiveness against alleged venom of scorpions and snakes. In this work, we tested for the first time, the anti-venomous activity of Artemisia campestris L against the scorpion Androctonus australis garzonii and the viper Macrovipera lebetina venoms. Assays were conducted by fixing the dose of extract to3 mg/mouse while doses of venom are variable. The leaves of Artemisia campestris L were extracted by various organic solvents (Ether of oil, ethyl acetate, methanol and ethanol) and each extract was tested for its venom neutralizing capacity. For the ethanolic extract, a significant activity with respect to the venoms of scorpion Androctonus australis garzonii (Aag), was detected. Similarly, a significant neutralizing activity against the venom of a viper Macrovipera lebetina (Ml), was obtained with the dichloromethane extract. These results suggest the presence of two different type of chemical components in this plant: those neutralizing the venom of scorpion are soluble in ethanol whereas those neutralizing the venom of viper are soluble in dichloromethane.


Assuntos
Artemisia , Medicina Tradicional , Fitoterapia/métodos , Extratos Vegetais/farmacologia , Venenos de Escorpião/antagonistas & inibidores , Venenos de Víboras/antagonistas & inibidores , Animais , Artemisia/química , Bioensaio , Avaliação Pré-Clínica de Medicamentos , Etanol , Humanos , Dose Letal Mediana , Metanol , Camundongos , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Folhas de Planta , Picadas de Escorpião/tratamento farmacológico , Picadas de Escorpião/epidemiologia , Escorpiões , Mordeduras de Serpentes/tratamento farmacológico , Mordeduras de Serpentes/epidemiologia , Solubilidade , Solventes , Tunísia/epidemiologia
3.
Arch Inst Pasteur Tunis ; 79(1-4): 3-9, 2002.
Artigo em Francês | MEDLINE | ID: mdl-15072239

RESUMO

In this work, we provide experimental arguments in favor of the fact that components from Macrovipera lebetina and Cerastes cerastes venoms bind to IGR39 melanoma cells but not to HT29D4 cells that derive from carcinoma adenome. Furthermore, Macrovipera lebetina and Cerastes cerastes venoms inhibit the adherence of IGR39 and HT 29-D4 to various extracellular matrix proteins. Macrovipera lebetina and Cerastes cerastes venoms did not inhibit the non specific adherence of IGR 39 cells to polylysine. In addition, binding of components from Cerastes cerastes venom to IGR39 cells is inhibited by GRGDS peptide and by monoclonal antibidy anti-av, while these two components have no effect on the adherence of IGR39 to Macrovipera lebetina venom.


Assuntos
Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral/efeitos dos fármacos , Células HT29/efeitos dos fármacos , Integrinas/efeitos dos fármacos , Venenos de Víboras/farmacologia , Animais , Antineoplásicos/farmacologia , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Proteínas da Matriz Extracelular/efeitos dos fármacos , Humanos , Melanoma , Oligopeptídeos/farmacologia , Polilisina/efeitos dos fármacos , Tunísia , Venenos de Víboras/administração & dosagem
4.
Arch Inst Pasteur Tunis ; 79(1-4): 19-26, 2002.
Artigo em Francês | MEDLINE | ID: mdl-15072241

RESUMO

We report the use of recombinant scorpion toxin in the form of fusion protein as antigen for mice immunisation. The aim is to produce protective antisera against lethal activity of the venom from Tunisian scorpion Buthus occitanus tunetanus, responsible for several annually reported human cases of scorpion stings. The gene encoding Bot III (the most toxic alpha toxin of Buthus occitanus tunetanus) was fused to the sequence encoding synthetic ZZ domains of staphylococcal protein A. The construct ZZ-Bot III was expressed in the periplasm of E. coli as a fusion protein and purified by affinity chromatography. The recombinant fusion protein was characterized and used as antigen to generate antibodies in mice. The antibodies against the recombinant protein neutralize the toxic venom (10 LD50/ml) and also confer protection for immunized mice against antigenically related mammal toxins.


Assuntos
Antivenenos/uso terapêutico , Modelos Animais de Doenças , Imunoterapia/métodos , Proteínas Recombinantes de Fusão/uso terapêutico , Picadas de Escorpião/terapia , Venenos de Escorpião , Animais , Antivenenos/farmacologia , Cromatografia de Afinidade , Avaliação Pré-Clínica de Medicamentos , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Imunoterapia/normas , Camundongos , Reação em Cadeia da Polimerase , Estrutura Terciária de Proteína/genética , Proteínas Recombinantes de Fusão/farmacologia , Picadas de Escorpião/etiologia , Venenos de Escorpião/antagonistas & inibidores , Venenos de Escorpião/genética , Venenos de Escorpião/imunologia , Escorpiões , Proteína Estafilocócica A/genética , Tunísia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA